Alta Semper Fund II Secures EIB Investment to Expand Access to Affordable Healthcare in Africa

Alta Semper Fund II Secures EIB Investment to Expand Access to Affordable Healthcare in Africa. Photo credit: IEB

(IN BRIEF) The European Investment Bank, via EIB Global, has invested $37.5 million in Alta Semper Fund II to support pharmaceutical, life sciences and MedTech companies across Africa, with a primary focus on North Africa. The fund is expected to mobilise up to $150 million in total, promoting innovation, affordability and regional healthcare resilience while strengthening EU–Africa cooperation. With a strong emphasis on gender equality and inclusive growth, Alta Semper Fund II aims to expand access to quality healthcare, support local manufacturing and catalyse private investment across key African markets.

(PRESS RELEASE) LUXEMBOURG, 14-Jan-2026 — /EuropaWire/ — The European Investment Bank, through its development arm EIB Global, has committed $37.5 million to Alta Semper Fund II, a healthcare-focused private equity fund aimed at accelerating investment across Africa, with a strong emphasis on North Africa. The investment is expected to catalyse up to $150 million in total financing, supporting the growth of pharmaceutical, life sciences and medical technology companies while strengthening regional healthcare systems and EU–Africa cooperation.

Managed by Alta Semper Capital, a female-led investment firm with a strong track record in healthcare, the fund will primarily target North Africa, which is expected to account for around 70% of investments, alongside selected opportunities in sub-Saharan Africa. The fund’s strategy focuses on expanding access to affordable, high-quality healthcare products and services, supporting local manufacturing, innovation and sustainability across the healthcare value chain.

The commitment was formalised in Cairo during an event attended by Egypt’s Minister of Planning, Economic Development and International Cooperation H.E. Rania Al-Mashat, EIB Vice-President Gelsomina Vigliotti, Alta Semper Capital CEO Afsane Jetha, and IFC Division Director for North Africa and the Horn of Africa Cheick-Oumar Sylla. The initiative highlights growing collaboration between European and African development partners in strengthening resilient healthcare ecosystems.

Alta Semper Fund II will invest in companies active in pharmaceuticals, medical equipment and healthcare technologies, helping them scale operations, improve regional access to care and create skilled employment. Many portfolio companies are expected to collaborate with European suppliers and MedTech firms, reinforcing links between African healthcare markets and the European Union’s life sciences value chain.

Gender equality is a core pillar of the fund’s investment approach. At least 30% of portfolio companies are expected to advance gender equality, including through support for women-led enterprises, inclusive employment practices and leadership development. This focus aligns with broader development goals aimed at inclusive growth and human capital development.

The investment reflects EIB Global’s strategy of mobilising private capital alongside experienced fund managers capable of acting as catalysts in local markets. Alta Semper Fund II also benefits from international investor cooperation, including participation from the International Finance Corporation of the World Bank Group, with additional private investors in advanced discussions ahead of the fund’s final closing.

Aligned with the EU Global Health Strategy and the EU–Africa Global Gateway Investment Package, the initiative supports stronger regional manufacturing capacity, innovation and health security. By crowding in additional development finance institutions and private capital, Alta Semper Fund II is expected to deliver broader economic and social impact, improving healthcare access while reinforcing sustainable cooperation between the European Union and its Southern Neighbourhood.

Background information

About EIB Global

The European Investment Bank (ElB) is the long-term lending institution of the European Union, owned by its Member States. It finances investments that contribute to EU policy objectives.

EIB Global is the EIB Group’s specialised arm devoted to increasing the impact of international partnerships and development finance, and a key partner of the Global Gateway. It aims to support around €100 billion of investment by the end of 2027. EIB Global brings the EIB Group closer to people, companies and institutions through its offices across the world. Photos of EIB headquarters for media use are available here.

About the EIB Group

The EIB Group, consisting of the European Investment Bank and the European Investment Fund, is the biggest multilateral financial institution in the world and one of the largest providers of finance for climate action. As the bank of the European Union, its shareholders are the EU Member States, and it works in close collaboration with the European Commission. The EIB Group’s policy priorities are financing small and medium firms, innovation, digital and human capital, sustainable cities and regions, and sustainable energy and natural resources. Its work extends beyond Europe to over 160 countries.

About the Global Gateway Investment Agenda

EIB Global is a key partner in the implementation of the European Union’s Global Gateway Investment Agenda, supporting sound projects that improve global and regional connectivity in the digital, climate, transport, health, energy and education sectors. Investing in connectivity is at the very heart of what EIB Global does, building on the Bank’s 65 years of experience in this domain.

About Alta Semper Capital

Alta Semper Capital is a private equity firm focused on investing in healthcare, health-tech and consumer health opportunities across high-growth markets. Key investments include Macro Pharmaceuticals (Egypt’s leading cosmeceutical and generics pharma company), ODM (Morocco’s leading oncology, radiology and diagnostics platform), MYDAWA (Africa’s leading online pharmacy & telemedicine platform) and Allmed Medical (a leading innovator & manufacturer of renal care products, as well as the largest medical device manufacturer focussed on renal care across the Global South).

About IFC

IFC — a member of the World Bank Group — is the largest global development institution focused on the private sector in emerging markets. We work in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developing countries. In fiscal year 2025, IFC committed a record $71.7 billion to private companies and financial institutions in developing countries, leveraging private sector solutions and mobilizing private capital to create a world free of poverty on a liveable planet. For more information, visit www.ifc.org.

Media contact:
Enrico Possenti
e.possenti@eib.org
+352 4379 – 82144

Press Office
press@eib.org
+352 43791

SOURCE: European Investment Bank